When a fixed regulatory deadline meets withheld evidence and shifting interpretations, questions follow. This open letter examines how the UK Food Standards Agency has applied its CBD novel foods rules—and whether those decisions can be properly scrutinised.

To me, both May’s and Atkins’ paths highlighted what I think is the biggest conflict... the dinner conversation.

if the policies governing CBD products have been shaped by researchers with undeclared industry ties — especially when those policies affect thousands of businesses and millions of consumers — then there must be accountability.

This isn’t just about hemp or novel foods — it’s about the entire framework of cannabis regulation in the UK, how that framework was shaped, and who shaped it.

This is bigger than novel foods. This is about regulatory manipulation and undeclared conflicts of a senior Civil Servant when investigating a complaint that was made in the public interest.

How did 'Skunk' end up on an MHRA Yellow Card list meant for medicines and vaccines? And why does the timeline perfectly align with GW Pharm